S100A8 overexpression in high-grade breast tumors in comparison to low-grade tumors has been previously reported [51] and associated with poor prognosis, poor tumor differentiation, LVI, and node metastasis when co-expressed with S100A9 [52]. This evidence concerns the gene S100A8 and breast neoplasm.